Share Search
Visit the Share Search
You are here:
Celadon Pharmaceuticals Accounts Summary
| Date of Accounts | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2023 | 31-12-2022 | 31-12-2021 | 30-08-2020 | 30-08-2019 |
| Revenue | 0.07 | 0.02 | n/a | n/a | n/a |
| Operating Profit / Loss | -5.93 | -5.38 | -2.71 | -0.19 | -0.21 |
| Net Interest | -0.57 | -0.02 | -1.31 | 0.01 | 0.01 |
| Pre Tax Profit | -7.52 | -18.12 | -4.80 | -0.17 | -0.19 |
| Post Tax Profit | -7.26 | -17.41 | -4.78 | -0.17 | -0.19 |
| Profit for the Period | -7.26 | -17.41 | -4.78 | -0.17 | -0.19 |
| Equity Holders of Parent Company | -7.14 | -17.01 | -4.63 | -0.17 | -0.19 |
| Minority Interests | -0.12 | -0.41 | -0.16 | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | -11.50p | -29.70p | -7.87p | -2.85p | -3.60p |
| Earnings per Share (Diluted) | -11.50p | -29.70p | -7.87p | -2.85p | -3.60p |
| Earnings per Share (Adjusted) | -11.50p | -29.70p | -7.87p | -2.85p | -3.60p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -11.50p | -29.70p | -7.87p | -2.85p | -3.60p |
| Earnings per Share (Diluted) | -11.50p | -29.70p | -7.87p | -2.85p | -3.60p |
| Earnings per Share (Adjusted) | -11.50p | -29.70p | -7.87p | -2.85p | -3.60p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2023 | 31-12-2022 | 31-12-2021 | 30-08-2020 | 30-08-2019 |
| Non-Current Assets | |||||
| Intangible Assets | 0.33 | 0.43 | 1.17 | n/a | n/a |
| Property, Plant and Equipment | 6.17 | 6.28 | 3.31 | n/a | n/a |
| Investments | 0.22 | 0.22 | 0.20 | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Assets | 6.72 | 6.92 | 4.67 | n/a | n/a |
| Current Assets | |||||
| Inventories | 0.06 | 0.02 | n/a | n/a | n/a |
| Trade and Other Receivables | 1.14 | 1.25 | 0.26 | 0.01 | 0.02 |
| Cash at Bank and in Hand | 1.26 | 5.06 | 3.82 | 5.49 | 5.65 |
| Current Asset Investments | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 0.04 | n/a | n/a | n/a | n/a |
| Total Current Assets | 2.50 | 6.33 | 4.09 | 5.50 | 5.66 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 9.22 | 13.25 | 8.76 | 5.50 | 5.66 |
| Current Liabilities | |||||
| Borrowings | 0.07 | 0.07 | 7.43 | n/a | n/a |
| Other Current Liabilities | 0.88 | 1.13 | 1.15 | 0.03 | 0.02 |
| Total Current Liabilities | 0.95 | 1.20 | 8.58 | 0.03 | 0.02 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | 4.64 | 4.57 | 4.49 | n/a | n/a |
| Provisions | 0.44 | 0.45 | 0.09 | n/a | n/a |
| Other Non-Current Liabilities | n/a | n/a | n/a | 0.01 | 0.01 |
| Total Non-Current Liabilities | 5.09 | 5.02 | 4.57 | 0.01 | 0.01 |
| Net Assets | 3.18 | 7.04 | -4.40 | 5.46 | 5.63 |
| Capital and Reserves | |||||
| Share Capital | 0.64 | 0.62 | 0.08 | 0.06 | 0.06 |
| Share Premium Account | 25.50 | 22.55 | 7.37 | 5.71 | 5.71 |
| Other Reserves | 7.74 | 7.31 | -5.79 | 0.05 | 0.05 |
| Retained Earnings | -30.73 | -22.81 | -5.80 | -0.37 | -0.19 |
| Shareholders Funds | 3.16 | 7.67 | -4.14 | 5.46 | 5.63 |
| Minority Interests / Other Equity | 0.02 | -0.64 | -0.26 | n/a | n/a |
| Total Equity | 3.18 | 7.04 | -4.40 | 5.46 | 5.63 |
| 31-12-2023 | 31-12-2022 | 31-12-2021 | 30-08-2020 | 30-08-2019 | |
| Operating Margin | -7,908.00% | -22,420.83% | -135,650.00% | n/a% | n/a% |
| Return on Capital Employed | n/a% | n/a% | n/a% | n/a% | n/a% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | n/a | n/a | n/a | n/a | n/a |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | 4.44p | 10.29p | -8.66p | 8.50p | 8.77p |